Australia markets closed

BELLUS Health Inc. (BLU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.49-0.31 (-3.52%)
At close: 04:00PM EDT
8.49 0.00 (0.00%)
After hours: 04:42PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 943.31M
Enterprise value 710.19M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)47.49k
Price/book (mrq)3.36
Enterprise value/revenue 44.39k
Enterprise value/EBITDA -10.18

Trading information

Stock price history

Beta (5Y monthly) -0.50
52-week change 3118.81%
S&P500 52-week change 3-6.14%
52-week high 39.84
52-week low 32.60
50-day moving average 37.54
200-day moving average 36.37

Share statistics

Avg vol (3-month) 3774.36k
Avg vol (10-day) 3891.63k
Shares outstanding 5106.75M
Implied shares outstanding 6N/A
Float 861.41M
% held by insiders 111.27%
% held by institutions 188.92%
Shares short (28 Apr 2022) 411.47M
Short ratio (28 Apr 2022) 413.81
Short % of float (28 Apr 2022) 4N/A
Short % of shares outstanding (28 Apr 2022) 410.74%
Shares short (prior month 30 Mar 2022) 410.73M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Aug 2019
Ex-dividend date 4N/A
Last split factor 2277:1000
Last split date 318 Aug 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-454,187.50%

Management effectiveness

Return on assets (ttm)-20.90%
Return on equity (ttm)-33.82%

Income statement

Revenue (ttm)16k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)0.00%
Gross profit (ttm)16k
EBITDA N/A
Net income avi to common (ttm)-69.83M
Diluted EPS (ttm)-0.81
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)233.97M
Total cash per share (mrq)2.19
Total debt (mrq)845k
Total debt/equity (mrq)0.30
Current ratio (mrq)15.33
Book value per share (mrq)2.62

Cash flow statement

Operating cash flow (ttm)-60.13M
Levered free cash flow (ttm)-31.8M